BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12852696)

  • 1. Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
    Tandstad T; Klepp O
    Acta Oncol; 2003; 42(3):202-6. PubMed ID: 12852696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase--a serum tumour marker in seminoma?
    Fosså SD; Klepp O; Paus E
    Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
    Kuzmits R; Schernthaner G; Krisch K
    Cancer; 1987 Sep; 60(5):1017-21. PubMed ID: 2440552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific enolase: a serum tumor marker in malignant germ-cell tumors?
    Gross AJ; Dieckmann KP
    Eur Urol; 1993; 24(2):277-8. PubMed ID: 8397089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
    Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
    Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An immunohistochemical study on neuron specific enolase in testicular germ cell tumors].
    Ujié T; Monma N
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):297-304. PubMed ID: 1645819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
    Fosså A; Fosså SD
    Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
    Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
    J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
    Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
    Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumour markers in testicular and extragonadal germ cell malignancies.
    Klepp O
    Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ.
    Kang JL; Rajpert-De Meyts E; Skakkebaek NE
    J Pathol; 1996 Feb; 178(2):161-5. PubMed ID: 8683382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.